|
|
Article: New Study Showed Ramelteon Helped Adults With Chronic Insomnia Fall Asleep, Sleep Longer.
- Article from:
- PR Newswire
- Article date:
- June 20, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DENVER, June 20 /PRNewswire/ -- Ramelteon, a novel investigational compound under review with the FDA for the treatment of insomnia, reduced the time it took to fall asleep and increased total sleep time in adults with chronic insomnia, according to results from a Phase 3 study presented this week at the 19th Annual Meeting of the Associated Professional Sleep Societies (APSS). Results of the study also showed no evidence of rebound insomnia, next-day impairments or withdrawal effects due to discontinuation.
According to the American Insomnia Association, more than 20 million Americans have complaints of chronic insomnia, a condition in which an individual ...
Related newspaper, magazine, and journal articles:
|
|
Article: Takeda Pharmaceuticals North America Names ...
PR Newswire;
November 22, 2005 ;
700+ words
... ... 22 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. (TPNA ... Booth, president of Takeda Pharmaceuticals North America. "We're ... Chicago School of Law. Takeda Pharmaceuticals North America, Inc. Based ...
|
|